Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Kalyanasundaram R, Khatri V, Chauhan N (2020) Advances in vaccine development for human lymphatic filariasis. Trends Parasitol 36(2):195–205. https://doi.org/10.1016/j.pt.2019.11.005
2. Deshpande A, Miller-Petrie MK, Lindstedt PA, Baumann MM, Johnson KB, Blacker BF et al (2020) The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis. Lancet Glob Health 8(9):e1186–e1194. https://doi.org/10.1016/s2214-109x(20)30286-2
3. Raju K, Jambulingam P, Sabesan S, Vanamail P (2010) Lymphatic filariasis in India: epidemiology and control measures. J Postgrad Med 56(3):232–238. https://doi.org/10.4103/0022-3859.68650
4. Taylor MJ, Hoerauf A, Bockarie M (2010) Lymphatic filariasis and onchocerciasis. Lancet (London, England) 376(9747):1175–1185. https://doi.org/10.1016/s0140-6736(10)60586-7
5. WHO (2017) WHO guidelines approved by the guidelines review committee. guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis. Geneva: World Health Organization. Copyright © World Health Organization 2017. PMID 29565523
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献